September 26, 2017 - By marketbeat
CADUCEUS SOFT SYSTEMS (OTCMKTS:CSOC) had a decrease of 36.67% in short interest. CSOC’s SI was 3,800 shares in September as released by FINRA. Its down 36.67% from 6,000 shares previously. It closed at $0.001 lastly. It is down 0.00% since September 26, 2016 and is . It has underperformed by 16.70% the S&P500.
Martin Currie Ltd increased Banco Santander Chile New (BSAC) stake by 1.46% reported in 2017Q2 SEC filing. Martin Currie Ltd acquired 13,300 shares as Banco Santander Chile New (BSAC)’s stock rose 10.93%. The Martin Currie Ltd holds 924,683 shares with $23.50 million value, up from 911,383 last quarter. Banco Santander Chile New now has $14.05B valuation. The stock decreased 2.62% or $0.8 during the last trading session, reaching $29.69. About shares traded. Banco Santander-Chile (ADR) (NYSE:BSAC) has risen 30.67% since September 26, 2016 and is uptrending. It has outperformed by 13.97% the S&P500.
Caduceus Software Systems Corp is a development stage company. The company has market cap of $794,200. The Firm is in the business of providing medical software to medical professionals. It currently has negative earnings. It has not generated any revenue to date.
Among 4 analysts covering Banco Santander-chile (NYSE:BSAC), 0 have Buy rating, 1 Sell and 3 Hold. Therefore 0 are positive. Banco Santander-chile had 7 analyst reports since November 2, 2015 according to SRatingsIntel. The rating was maintained by JP Morgan on Monday, November 2 with “Neutral”. Credit Suisse downgraded it to “Neutral” rating and $20 target in Monday, March 7 report. The company was upgraded on Thursday, November 10 by Credit Suisse. The stock of Banco Santander-Chile (ADR) (NYSE:BSAC) has “Equalweight” rating given on Thursday, April 7 by Barclays Capital. The stock of Banco Santander-Chile (ADR) (NYSE:BSAC) earned “Underperform” rating by Bank of America on Wednesday, September 7. As per Wednesday, April 19, the company rating was downgraded by Credit Suisse.
Martin Currie Ltd decreased Mastercard Incorporated (NYSE:MA) stake by 5,066 shares to 6,500 valued at $789,000 in 2017Q2. It also reduced Jpmorgan Chase & Co (NYSE:JPM) stake by 73,629 shares and now owns 182,158 shares. Pfizer Inc (NYSE:PFE) was reduced too.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.